(Q34459831)

2 August 2017

OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis (English)

1 reference

2 August 2017

0 references

1 reference

4

Daniel J Clauw

1 reference

2 August 2017

2

Tanya L Hoskin

1 reference

2 August 2017

Ann Vincent

1

1 reference

2 August 2017

Mary O Whipple

3

1 reference

2 August 2017

Debra L Barton

5

1 reference

2 August 2017

Roberto P Benzo

6

1 reference

2 August 2017

David A Williams

7

1 reference

2 August 2017

16 October 2014

1 reference

Arthritis Research and Therapy

2 August 2017

1 reference

2 August 2017

16

1 reference

2 August 2017

5

1 reference

2 August 2017

463

1 reference

https://scigraph.springernature.com/pub.10.1186/s13075-014-0463-7

2 August 2017

0 references

cites work

Construction of a US fibromyalgia registry using the Fibromyalgia Research Survey criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Cluster analysis of clinical data identifies fibromyalgia subgroups

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Psychological control is a key modulator of fibromyalgia symptoms and comorbidities

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Ques

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Delineating psychological and biomedical profiles in a heterogeneous fibromyalgia population using cluster analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

The science of fibromyalgia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Further validation of the Multidimensional Fatigue Inventory in a US adult population sample

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Fibromyalgia syndrome module at OMERACT 9: domain construct

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Toward the identification of symptom patterns in people with fibromyalgia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Milnacipran hydrochloride: its efficacy, safety and tolerability profile in fibromyalgia syndrome

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

A brief measure for assessing generalized anxiety disorder: the GAD-7.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

SF-36 health survey update

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Fibromyalgia syndrome in men.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Pain assessment: global use of the Brief Pain Inventory

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221670

Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Development and validation of a Multiple Ability Self-Report Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Are there gender differences in quality of life and symptomatology between fibromyalgia patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Gender differences among patients with fibromyalgia undergoing multidisciplinary pain rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Prevalence of fibromyalgia: a survey in five European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

A comparison study of quality of life in women with fibromyalgia and myofascial pain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

The longitudinal outcome of fibromyalgia: a study of 1555 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-014-0463-7

Fibromyalgia: poorly understood; treatments are disappointing

21 January 2018

1 reference

12 December 2020

Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study

1 reference

12 December 2020

Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment

1 reference

12 December 2020

Estimation of minimum clinically important difference for pain in fibromyalgia

1 reference

12 December 2020

10.1186/S13075-014-0463-7

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference